These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13852743)

  • 1. [Early results of the use of 2-p-chlorophenyl-3-methyl-2,3-butanediol (phenaglycodol) in neuropsychiatric therapy].
    IMBERCIADORI E
    Minerva Med; 1960 Mar; 51():757-60. PubMed ID: 13852743
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the potentiating action of alpha-phenyl-alpha-(p-chlorophenyl)-4-pyridinemethanol (chronaxil) in some mental disorders being treated with 2-p-clorophynyl-3-methyl-2,3-butanediol].
    LUCKENBACH F; MICHELETTO T
    Gazz Med Ital; 1960 Aug; 119():328-30. PubMed ID: 13764033
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of the analgesic effect of dextropro-poxyphene hydrochloride, phenaglycodol, and aspirin combination (darvo-tran).
    SETTEL E
    Antibiotic Med Clin Ther (New York); 1959 Sep; 6():512-7. PubMed ID: 14445201
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenaglycodol therapy in cerebral palsy.
    KUGELMASS IN
    Ann N Y Acad Sci; 1958 Oct; 72(8):271-92. PubMed ID: 13583888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification and urinary elimination of phenaglycodol].
    CIMA L; FASSINA G
    Farmaco Prat; 1959 Jul; 14():416-23. PubMed ID: 13849393
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenaglycodol: a new antiepileptic agent.
    GRUBER CM; MOSIER JM
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):384-5. PubMed ID: 13408268
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of phenaglycodol (ultran), meprobamate and a placebo in abstinent alcoholics.
    SMITH JA; RUTHERFORD A; FANNING R
    Am J Psychiatry; 1957 Oct; 114(4):364-5. PubMed ID: 13458502
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of phenaglycodol, a new neurosedative agent.
    JONES GT; SLATER IH; YOUNG WK
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):528-31. PubMed ID: 13389510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Place of a new neuroleptic, Dominal, in neuropsychiatric therapy].
    COUSIN JP
    Sem Hop Ther Paris; 1961 Jun; 37():544-6. PubMed ID: 13881803
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of phenaglycodol and meprobamate on anxiety reactions.
    ZUKIN P; ARNOLD DG; KESSLER CR
    J Nerv Ment Dis; 1959 Aug; 129():193-5. PubMed ID: 13847900
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of clinical use of hydroxyphenamate in 1759 patients.
    HUBATA JA; HECHT RA
    Clin Med (Northfield); 1962 Jul; 69():1594-8. PubMed ID: 15445778
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance and withdrawal hyperexcitability induced in mice by chronic administration of phenaglycodol.
    CHIN L; SWINYARD EA
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):251-4. PubMed ID: 13518240
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentylenetetrazol seizure threshold in meprobamate- and phenaglycodol-treated mice.
    CHIN L; SWINYARD EA
    J Am Pharm Assoc Am Pharm Assoc; 1959 Jan; 48(1):6-8. PubMed ID: 13610718
    [No Abstract]   [Full Text] [Related]  

  • 14. A report on the apparent anticonvulsant effect of hydroxyphenamate (Listica).
    ABBOTT JA; SCHOLL ML; SCHWAB RS; ENGLAND AC
    Dis Nerv Syst; 1962 Sep; 23():519-21. PubMed ID: 13858828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positive effect of phenaglycodol on characterologic disorders in epileptic patients].
    Szemraj J; Janusz A; Lenartowska K
    Neurol Neurochir Pol; 1968; 2(3):445-7. PubMed ID: 4880821
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effect of phenaglycodol, meprobamate, and a placebo on the irritable colon; a double-blind study.
    KASICH AM; FEIN HD; MILLER JW
    Am J Dig Dis; 1959 Mar; 4(3):229-34. PubMed ID: 13626924
    [No Abstract]   [Full Text] [Related]  

  • 17. A preliminary report on the continued post-hospital use of tranquilizing drugs.
    WOLFF RJ; COLACINO DM
    Am J Psychiatry; 1961 Dec; 118():499-503. PubMed ID: 14008038
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of phenaglycodol in biologic specimens by ultraviolet spectrophotometry.
    Wallace JE
    J Pharm Sci; 1968 Mar; 57(3):426-9. PubMed ID: 5655580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Levomepromazin (nozinan, 7044 R. P.) in the treatment of mental disorders].
    RIDANOVIC S
    Neuropsihijatrija; 1961; 9():63-76. PubMed ID: 13741463
    [No Abstract]   [Full Text] [Related]  

  • 20. Thioridazine in treatment of mental disorders.
    AIVAZIAN GH
    J Tn State Med Assoc; 1959 Nov; 52():446-7. PubMed ID: 13792212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.